Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation-Reference-Cited by-同舟云学术

Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation

Published:2024-05-06 Issue:6 Volume:32 Page:707-723
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Adin Syeda Nashvia¹^ORCID,Gupta Isha¹^ORCID,Aqil Mohd²^ORCID,Mujeeb Mohd¹^ORCID,Najmi Abul Kalam³^ORCID

Affiliation:

1. Phytomedicine Laboratory, Department of Pharmacognosy & Phytochemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India

2. Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India

3. Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2024.2347371

Reference31 articles.

1. The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis

2. Photoacoustic/ultrasonic dual-mode imaging for monitoring angiogenesis and synovial erosion in rheumatoid arthritis

3. Inhibitory effects of Ganoderma lucidum spore oil on rheumatoid arthritis in a collagen-induced arthritis mouse model

4. An intra‐articular injectable phospholipids‐based gel for the treatment of rheumatoid arthritis

5. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in rheumatoid arthritis therapy: a journey from conventional therapy to precision medicine via nanoparticles targeting immune cells;Nanoscale;2024